Lara EA, González CA, Amancio CO, Arceo GM, Alexanderson RG, Ortíz SG, Velázquez MO

Language: Spanish
References: 8
Page: 266-272
PDF size: 85.33 Kb.

ABSTRACT

Background: Most of the non transmissible chronic diseases of high prevalence can be prevented. For this, it is important to identify prediction factors that allow us to create strategies in order to reduce its presentation.
Objective: To propose the application of low height and waist perimeter as tools to predict the risk of non transmissible chronic diseases.
Patients and methods: During the years 2001 and 2002 the study of the six cities was made. A survey was applied to 150 persons per day. In them we could identify some risk factors, as: nicotinism, acute myocardial infarction, cerebral vascular disease, weight, height, capillary glucose, arterial pressure, and cholesterol.
Results: We studied 120,028 subjects. The total prevalence of low height was of 20%, and it was observed that it was greater in women than in men. Low height subjects are more prone to have diabetes, hypertension and hypercholesterolemia than those with normal height.
Conclusions: Low height in Mexican population is an independent cardiovascular risk factor that should be considered when evaluating it, as the risk of presenting diabetes and hypertension increases when the body mass index is of 23 in the subjects with low height.

REFERENCES

1. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Grupo ENSA 2000, Sánchez-Castillo C, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Inst Cardiol Mex 2003;73(1):62-77.

2. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Grupo ENSA 2000, Sánchez-Castillo C, et al. Hipertensión arterial en México: resultados de ENSA, 2000. Arch Cardiol Mex 2002;72:71-84.

3. Velázquez MO, Lara EA, Tusie LMT, González ChA. Prevención primaria de la diabetes: una necesidad para el siglo XXI. Med Int Mex 2000;17(1):24-35.

4. Sánchez-Castillo CP, Velázquez-Monroy O, Berber A, Lara-Esqueda A, Tapia-Conyer R, James WP, et al. Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res 2003;11(3):442-51.

5. González CA, Becerra PA, Carmona SF, Cerezo GM, Hernández HE, Lara Esqueda A. Ejercicio físico para la salud. Rev Mex Cardiol 2001;12(4):168-80.

6. Lara A, Rosas M, Pastelín G, Aguilar C, Attie F, Velázquez MO. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004;74(3):231-45.

7. Lara-Esqueda A, Aguilar-Salinas CA, Velázquez-Monroy O, et al. The body mass index is a less-sensitive tool for detecting cases with obesity-associated co-morbidities in short stature subjects. Int J Obes Relat Metab Disord 2004;28(11):1443-50.

8. Sánchez-Castillo CP, Velázquez-Monroy O, Lara-Esqueda A, Sepúlveda J, Tapia-Conyer R, James WP. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr 2005;8(1):53-60.